Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Michaela Reagan
Multiple Myeloma
Kura Oncology
MLL leukemia, AML
Sahand Hormoz
MPN
Eric Padron
CMML
Robert Soiffer
transplantation
Kimberly Stegmaier
childhood blood cancers
Kirk Schultz
pediatric transplantation
Lori Muffly
Equity in Access
Gianpietro Dotti
CAR T and AML
Margaret Shipp
lymphoma biology
Ricky Johnstone
lymphoma and myeloma
James Rubenstein
Lymphoma of the Central Nervous System
Peter Klein
MDS
Jeremy Baeten
AML
Raymond Mailhot
Equity in Access
Hong Wen
AML
Stephen Gottschalk
pediatric leukemia and CAR-T
Gareth Morgan
smoldering myeloma, MGUS
Yubin Zhou
peripheral T cell lymphoma
Marc Seifert
Hairy cell leukemia
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Carl June
CAR T immunotherapy
Michael Savona
MDS and leukemia
Adam Olszewski
Follicular and marginal zone lymphoma
BioInvent International
immunotherapy, indolent NHL, CTCL
Ann-Kathrin Eisfeld
Racial diversity in AML
Neha Mehta-Shah
T-cell lymphoma
Siegfried Janz
Myeloma immunotherapy
Timothy Graubert
AML and MDS biology
Ryan Wilcox
T-cell lymphoma
Brian Dalton
DNA mutations and myeloid cancers
Jalpa Doshi
Equity in Access
Sarah Tasian
pediatric leukemias
Nicolas Nassar
pediatric leukemia
John DiPersio
trispecific antibody for AML and MDS
John Crispino
myelofibrosis, pediatric leukemia and Downs
William Matsui
Myeloma
Eugenio Morelli
Myeloma
Ari Melnick
epigenetics and lymphoma
Enterome
vaccine, FL, MZL
Koichi Takahashi
AML/MDS
Stephen Nimer
myeloid cancer biology
Susan Schwab
cancer immunology
Catherine Smith
leukemia
Liran Shlush
pre-leukemia
Dimericon Therapeutics
dimericons, blood cancer
Sriram Sundaravel
AML stem cells
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Marco Ruella
Immunotherapy for T-cell lymphoma
Constellation Pharmaceuticals
myeloproliferative neoplasms
Rajni Kumari
AML
Kathleen Sakamoto
pediatric AML
Michael Green
lymphoma biology
Wendy Béguelin
follicular lymphoma
Nitin Jain
CLL
Fahmin Basher
transplant and GvHD
Teresa Palomero
Peripheral T-cell Lymphoma
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Ruben Carrasco
Myeloma
Sergei Doulatov
Leukemias
Yiman Liu
Epigenetics and leukemia
George Daley
"off-the-shelf" CAR-T and CAR-NK
Ravi Bhatia
transplantation
Peter Croucher
Multiple Myeloma
Matteo Bellone
Smoldering multiple myeloma
Christian Marinaccio
MLL leukemias
Jayna Mistry
aging and leukemias
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Qing Yi
Novel CAR-T
Ana Vujovic
AML
Noemí Puig Morón
Myeloma
Lindsey Montefiori
pediatric leukemia
Adi Nagler
Bronchiolitis obliterans after transplant
Jolanta Grembecka
leukemia therapeutics
Bing Carter
p53 mutant AML
Joachim Yahalom
Lymphoma
Nicola Vannini
Aging and CAR-T success
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Michael Wang
Mantle Cell Lymphoma
Taishi Yonezawa
AML
Simona Colla
Myeloma biology
Jun Qi
Myeloma
Suman Paul
T cell cancers and immunotherapy
Hao Jiang
DNA biology and leukemia
Richard Lock
T-ALL
Nizar Bahlis
Myeloma immunotherapy
Britta Will
Leukemia and pre-leukemia
Tak Mak
Immunotherapy
Daisuke Nakada
preleukemia, leukemia
Nicoletta Cieri
AML and transplantation
Courtney Jones
AML metabolism
Brian Walker
smoldering myeloma, MGUS
Piers Patten
COVID-19
Jeetayu Biswas
splicing in myeloid diseases
Saar Gill
AML immunotherapy
Mendel Goldfinger
MDS/AML trials for the elderly
Shazia Nakhoda
Equity in Access
Christopher Flowers
clinical trial access
Jeffrey Magee
pediatric AML
Luca Busino
DLBCL
Reina Takeda
AML
Andrew Lane
BPDCN
Inhye Ahn
CLL
Sisi Chen
leukemia
Tycel Phillips
Mantle Cell Lymphoma
Meng Li
Equity in Access
Kasey Leger
pediatric blood cancers
Maximilian Stahl
AML immunotherapy
Elliot Stieglitz
CMML
Christian Steidl
B-cell lymphomas
John Leonard
lymphoma research
Nirav Shah
CAR-T for lymphoma
Jonathon Cohen
lymphoma clinical trial access in Georgia
Affimed
immunotherapy, HL, PTCL
Liling Wan
AML
Wendy Stock
T-cell ALL
Rizwan Romee
Immunotherapy
Paola Aguilar Neuville
Primary cutaneous γδ T-cell lymphoma
Yibin Yang
Lymphoma
Jessica Stewart
Epstein-barr virus and lymphomas
Jing Yang
Myeloma
Daniel Thomas
Myelofibrosis
Christine Zhang
AML
Soheil Meshinchi
pediatric AML
Megan McNerney
AML/MDS
Anouchka Laurent
T-cell lymphoma
Lakshmi Nayak
brain tumors in lymphoma
Daniel Herranz
T-ALL
Philippe Armand
follicular lymphoma
Anthony Letai
improving CAR-T
Yoke Seng Lee
AML
Gaurav Goyal
Erdheim-Chester Disease
Srividya Swaminathan
pediatric, immunotherapy
Markus Muschen
leukemia and lymphoma biology
Alex Kentsis
pediatric leukemias
Solu Therapeutics
immunotherapy, CMML
Kerry Rogers
CLL
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Caner Saygin
T-ALL
Rgenta Therapeutics
RNA-targeting, blood cancer
Arash Alizadeh
blood cancer biology and diagnosis
Oreofe Odejide
Equity in Access
Tyler Parsons
MPN and AML
Steven Horwitz
T-cell lymphomas
Amit Verma
AML/MDS
Sham Mailankody
Myeloma immunotherapy clinical trials
Michael Keller
COVID-19, immunotherapy
Jianhua Yu
myeloma immunotherapy
Frederick Locke
lymphoma and immunotherapy
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Thomas Koehnke
leukemia
Jake Shortt
precision therapy for aggressive lymphomas
Craig Jordan
AML
Julia Maxson
AML
Thomas LeBlanc
palliative care
Suzanne Lentzsch
Myeloma
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Manyi Wei
acute megakaryoblastic leukemia
Daniel Starczynowski
MDS and AML
Carl Allen
pediatric blood cancers
Bingyi Chen
AML immunotherapy
Tomasz Skorski
myeloproliferative neoplasms, AML
Trent Hall
MDS
Xu Ji
Equity in Access
Armin Rashidi
gut bacteria and transplant success
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Alfred Garfall
myeloma immunotherapy
Cailin Collins
Leukemia and pre-leukemia
Alexey Danilov
lymphoma
Takeshi Sugio
T-cell lymphoma
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Matthew Frank
Lymphoma CART therapy
Ravindra Majeti
preleukemia, AML
Steven Treon
Lymphomas and Waldenstrom's
Jaehyuk Choi
T-cell lymphoma
Catherine Diefenbach
DLBCL immunology
Jing Fu
myeloma
Adam de Smith
pediatric ALL and Down Syndrome
Faron Pharmaceuticals
immunotherapy, MDS
Siddhartha Jaiswal
preleukemia
Randall Davis
CLL
Qingyu Luo
BPDCN
Lev Kats
myeloma and epigenetics
Dane Vassiliadis
blood cancer biology
Julia Paczkowska
immunobiology of Hodgkin's disease
Paolo Caimi
CAR-T clinical trial for CLL
Daniel Pollyea
AML
Jennifer Trowbridge
aging and leukemia
H. Irene Su
Equity in Access
Mark Murakami
follicular lymphoma
Riccardo Dalla-Favera
lymphoma (DLBCL)
Eric Pietras
AML
Keisuke Ito
blood cancer stem cells and MDS metabolism
Carma Bylund
Equity in Access
Alec Zhang
myeloma, immunotherapy
Rachel Mersfelder
AMKL
Areej El-Jawahri
transplant survivorship
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Jianguo Tao
Mantle Cell Lymphoma
Grzegorz Nowakowski
Clinical trial access
Daniel Lucas
bone marrow and leukemia biology
Venkata Lokesh Battula
immunotherapy and AML
Stacie Dusetzina
Equity in Access
Anushree Vichare
Equity in Access
Huda Salman
CMML
Robert Orlowski
(Smoldering) Multiple Myeloma
Justine Kahn
pediatric leukemia and lymphoma
Lucy Godley
preleukemia
Martin Dreyling
Mantle Cell Lymphoma
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Catherine Bollard
pediatric blood cancers and immunotherapy
Jonas Jutzi
myeloproliferative neoplasms
Shannon Maude
Immunotherapy for ALL
Bailee Kain
AML and African ancestry
Dan Landau
cancer evolution biology
Marina Konopleva
MDS/AML metabolism
Yan Liu
MDS
Mark Hamilton
DLBCL and CAR-T
Logan Spector
childhood leukemia epidimiology
Tanya Siddiqi
clinical trial access
Enrico Tiacci
Hairy cell leukemia
Pooja Khandelwal
bone marrow transplantation
Omar Abdel-Wahab
Hairy cell leukemia
George Vassiliou
Leukemia Prevention
Alieen Rowan
Adult T cell leukemia/lymphoma
Sam Butterworth
CMML
Paolo Strati
Non-Hodgkin Lymphoma
Madhav Dhodapkar
multiple myeloma immunotherapy
Eirini Papapetrou
blood cancer stem cells
Michael Kharas
leukemia
Ronald Levy
immunotherapies, COVID-19
Coleman Lindsley
AML/MDS
Christopher Booth
BPDCN
Catriona Jamieson
cancer stem cell biology
ImCheck Therapeutics
immunotherapy, AML
Christopher Porter
Leukemia, lymphoma
Lawrence Boise
CART and myeloma
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Sheng Li
Aging and AML
Frederike Kramer
MPNs
Caron Jacobson
lymphoma and immunotherapy
Pietro Genovese
transplant and AML
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Nataly Cruz-Rodriguez
T-ALL and metabolism
Urvi Shah
Diet and myeloma
Stephen Oh
myeloproliferative neoplasms
Mala Shanmugam
myeloma
Fenghuang Zhan
Myeloma and bone disease
F. Lennie Wong
Equity in Access
Bruno Paiva
smoldering myeloma
Jonathan Licht
DNA biology, myeloma
Roberta Zappasodi
lymphoma, immunotherapy
Paul Beavis
immunotherapy in myeloma
Jenny Wang
AML
Caroline Arber
myeloma CAR-T
Amin Sobh
Myeloma biology
Jean Koff
Disparities in DLBCL
Steven Park
follicular lymphoma
Helen Parsons
Equity in Access
Mark Dawson
B-ALL and CAR-T resistance
Roland Walter
Antibody-based AML therapies
Grant Challen
preleukemia, leukemia
Jennifer Woyach
CLL trials
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Leandro Cerchietti
DLBCL
Rong Lu
preleukemia, leukemia
Courtney DiNardo
clinical trials, AML
Alison Moskowitz
lymphoma therapeutics
Jaroslaw Maciejewski
bone marrow failure
Thomas Kipps
Hairy Cell Leukemia
Sigurður Kristinsson
Smoldering myeloma